Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

• John H Alexander,
• Christopher B Granger,
• Sigrun Halvorsen,
• Stephan Windecker,
• Dragos Vinereanu,
• Daniel M Wojdyla,
• Roxana Mehran,
• Shaun Goodman,
• Renato Lopes,
• Robert C. Welsh,
• Payam Dehghani,
• Ronald Aronson,
• Amit N Vora,
• Alexander Parkhomenko

Affiliations

John H Alexander

Cardiology, Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina, USA

Christopher B Granger

Cardiology, Duke University School of Medicine, Durham, North Carolina, USA

Sigrun Halvorsen

Cardiology, Oslo University Hospital and University of Oslo, Oslo, Norway

Stephan Windecker

Department of Cardiology, Swiss Cardiovascular Center, Bern, Switzerland

Dragos Vinereanu

Cardiology, Carol Davila University of Medicine and Pharmacy, Bucuresti, Romania

Daniel M Wojdyla

Cardiology, Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina, USA

Roxana Mehran

Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Shaun Goodman

Canadian Heart Research Centre, Toronto, Ontario, Canada

Renato Lopes

Cardiology, Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina, USA

Robert C. Welsh

Cardiac Sciences, University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada

Payam Dehghani

Medicine, Regina Qu`Appelle Health Region, Regina, Saskatchewan, Canada

Ronald Aronson

Bristol-Myers Squibb Co, Princeton, New Jersey, USA

Amit N Vora

Cardiology, Pinnacle Heart and Vascular Institue, Harrisburg, Pennsylvania, USA

Alexander Parkhomenko

Cardiology, National Scientific Center Academician M D Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine, Kiiv, Ukraine